App Intel

Lipid Manager

LiveAmerican College of Cardiology Foundation19 apps · 690.8K installsMedicalFreeorg.acc.ldlmanager

This clinical decision app is composed of 2-tools-in-1 for lowering ASCVD risk.

Alert me★ WatchOpen in Play ↗
Total installs
19,692
exact · Play shows 10,000+
Installs / day
0
7-day avg · last day 0
Rating
—★
— ratings · — reviews
Released
21 Feb 2017
9.6y ago
Last update
12 Jun 2026
v8.3 · 4mo ago
Countries
—
not checked yet

Install history

exact counter from Google Play
19.2K26.9K34.6K42.3K50K11 Oct12 Oct13 Oct
19.2K26.9K34.6K42.3K50K11 Oct12 Oct13 Oct

Installs per day · last 90 days

00.30.50.8112 Oct13 Oct13 Oct

Change timeline

Full history

No changes recorded yet. We compare every crawl with the previous one and list title, icon, screenshots, description, version, price and availability changes here.

Country availability

Availability has not been checked for this app yet. “Check all countries” looks the app up in about 140 Google Play storefronts and shows where it is live, listed but not installable, or missing — plus any country-specific (custom) store listings.

Top countries

Country data will be available soon.

We estimate where downloads come from using the app’s position in Google Play’s top charts in about 140 countries. This app is not in any chart we have collected yet; the estimate appears as soon as it is.

Top chart positions

Not in any tracked top chart.

App manifest

Read this app's manifest from Google Play: permissions, declared SDKs, components and AdMob app ID. Saved analysis appears here automatically.

Manifest analysis reads only the required APK ranges. Base APK downloads may need separate device splits to install.

Data safety

declared by the developer on Google Play
  • No data shared with third parties
  • Collects data App activity and Device or other IDs
  • Data is encrypted in transit

This is the developer's own declaration, summarised from the Play listing. The permissions below show what the app is technically able to access.

Permissions

5 in 1 group
0 Sensitive1 Notable4 Routine
OtherNotable5

Access to miscellaneous device features that don't fit other categories

  • Keep your phone's processor or screen from going to sleep, which can use more batteryprevent device from sleeping · WAKE_LOCK
  • Check whether you are online and whether you use Wi-Fi or mobile dataview network connections · ACCESS_NETWORK_STATE
  • Connect to the internet to load content and send datafull network access · INTERNET
  • Read Google service settings stored on your deviceread Google service configuration · com.google.android.providers.gsf.permission.READ_GSERVICES
  • Receive push messages sent from the app's servers over the internetreceive data from Internet · com.google.android.c2dm.permission.RECEIVE

Sensitive = can reach personal data, location, camera/mic or act on your behalf. Notable = changes how your device behaves. Routine = normal for almost every app. Source: Google Play's permission list for all versions of this app.

Store listing

Full description
The ACC Lipid Manager app provides two clinical decision support tools in one app to help clinicians manage a patient’s triglycerides and LDL-C from therapy initiation through treatment calibration with the goal of lowering ASCVD risk: •  Lipid Lowering Therapy tool: Supports selection of lipid‑lowering therapies and individualized goals to reduce ASCVD risk through targeted management of LDL-C and triglycerides (previously known as LDL-C Lowering Therapy) •  Statin Intolerance tool: Evaluate the patient for possible statin intolerance, and determine appropriate next steps The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgement. Therapeutic options should be determined after discussion between the patient and their care provider. Financial support for Lipid Manager was provided by Esperion. All content was independently developed with no sponsor involvement.

What's new

The Hypertriglyceridemia tool has been merged into the newly-renamed Lipid Lowering Therapy tool and now includes recommendations for the management of hypertriglyceridemia in accordance with the 2026 ACC/AHA Guideline on the Management of Dyslipidemia.

Similar apps

closest title first, then most installs per day